Jones J, et al. - In the prospective, multicenter, single-masked, randomized, controlled clinical trial, researchers investigated the safety and efficacy of Schlemm’s canal stenting in combination with cataract surgery to decrease IOP. They randomized 219 eyes to microstent implantation and 112 to phaco alone. They noticed a decline in unmedicated diurnal IOP (DIOP) by ≥20% in the microstent group (78.5% vs 54.5%) at 24 months. They also recorded a significant decline in medication usage with implantation of a Schlemm’s canal microstent following phacoemulsification vs phacoemulsification alone in outpatients with mild to moderate severity POAG. Overall, they concluded the combination procedure similar to cataract surgery alone in terms of visual acuity results and ocular adverse event rate.